JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Application Note
Download your application note on TGF-β SMAD α-SMA signaling in NASH
Discover the benefits of using HTRF assays to characterize liver fibrosis
Several molecular markers have been investigated as possible factors in the progression of non-alcoholic steatohepatitis (NASH) towards liver fibrosis.
The TGF-b/SMAD/α-SMA pathway has a crucial role in this progression and has emerged as an important therapeutic target.
This application note will allow you to:
- Get an overview of the liver fibrosis mechanism’s function and dynamics
- Take advantage of HTRF technology to study the TGF-β/SMAD/α-SMA signaling axis
- Benefit from additional content to help you revolutionize NASH discovery
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Download your application note on TGF-β SMAD α-SMA signaling in NASH